Private Equity
Inoki Suarez has joined Carlyle Group as a managing director for the firm’s private credit group within its global credit platform. Suarez was previously with Varagon Capital Partners, where he was co-head of general industries and a member of the firm’s initial launch team in 2014.
2 min read · 18 December 2017
Shervin Pishevar resigned from Sherpa Capital, the firm he co-founded, in the wake of accusations of sexual misconduct, according to a statement.
1 min read · 15 December 2017
Cloudvirga, a developer of intelligent mortgage point-of-sale platforms, has appointed Jim Portner as chief product officer. Previously, Portner worked at First American Financial Corporation where he was senior vice president of products and strategy. Cloudvirga’s backers include Dallas Capital, Upfront Ventures and Tribeca Angels.
2 min read · 15 December 2017
Los Altos, California-based Cibiem Inc, a medical device company, has appointed William H. Kucheman to its board of directors. Currently, Kucheman served as director of BioStar Ventures III, a medical device venture capital fund. Cibiem is backed by Third Rock Ventures, SV Health Investors and BioStar Ventures.
3 min read · 14 December 2017
Menlo Park, California-based GRAIL Inc, a life sciences company focused on detecting cancer early when it can be cured, has named Jennifer Cook as CEO. Her appointment becomes effective January 2, 2018. Bill Rastetter, the interim CEO since August 2017, will continue as chairman of the board of directors. And GRAIL has added Catherine Friedman and Min Cui to its board of directors. GRAIL's backers include ARCH Venture Partners, Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, Decheng Capital, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent and Varian Medical Systems.
5 min read · 14 December 2017
Bluerush Media Group Corp announced the appointment of John Eckert, co-founder of Canadian venture capital firm Round13 Capital, to the company’s board of directors. The appointment follows Round13’s investment in Bluerush’s $1.3 million private offering in October. Eckert, a co-founder and former managing partner of McLean Watson Capital, helped launch Round13 in 2012. Earlier this year, the firm raised $95 million for its growth-stage technology fund. Bluerush, a Toronto-based digital solutions provider, also said it appointed Steve Taylor as CEO.
4 min read · 14 December 2017
London-based venture firm Felix Capital, which raised $150 million for its second fund in the summer, announced it has added its first entrepreneur-in-residence and associate to the team. Joining as EIR is George Pallis who came over from Deliveroo, where he led global marketing, and before that was with Transferwise. Felix said Pallis will provide feedback on investment opportunities through his operator eye, especially on the consumer side. Joining as associate is Emilie Spire, who started in venture as an associate with Partech Ventures in Paris before moving to Blablacar in a corporate development and then operational role. Felix said Spire will spend time in France and work very closely with all of the team on deal sourcing,
1 min read · 13 December 2017
Bluerush Media Group Corp (TSX-V: BTV) announced the appointment of John Eckert, co-founder of Canadian venture capital firm Round13 Capital, to the company's board of directors. The appointment follows Round13's investment in Bluerush's $1.3 million private offering in October. Eckert, a co-founder and former managing partner of McLean Watson Capital, helped launch Round13 in 2012. Earlier this year, the firm raised $95 million for its growth-stage technology fund. Bluerush, a Toronto-based digital solutions provider, also said it appointed Steve Taylor as CEO.
4 min read · 13 December 2017
UK-based Atlas Genetics, a near patient and point-of-care testing company, has named Marc Jones as chief operating officer and chief financial officer. Previously, Jones worked at Good Start Genetics, where he served as COO and CFO. Atlas Genetics is backed by Novartis Venture Fund, Consort Medical, Wondfo Biotech, LSP Venture Capital, BB Biotech, Johnson & Johnson Innovation, RMI Investments and Southwest Ventures Fund.
3 min read · 13 December 2017
Accelerator Corp, a life science investment and management firm, has named Dr. Kendall Mohler as chief development officer and Ian Howes as chief financial officer. Previously, Mohler was senior vice president of research at Juno Therapeutics Inc while Howes was the CFO of Heart Metabolics.
4 min read · 13 December 2017
